Related Experiment Video
Updated: Jan 8, 2026

An Application for Pairing with Wearable Devices to Monitor Personal Health Status
Published on: February 3, 2022
Datasets of Smartphone Modalities for Depression Assessment: A Scoping Review
M L Tlachac1, Michael V Heinz2, Anastasia C Bryan3
1Department of Information Systems and Analytics, Bryant University, Smithfield, RI 02911 USA.
Abstract:
As mobile sensing research for depression assessment is rapidly expanding, it is vital to uncover fundamental patterns and overarching limitations in the datasets available for such research, especially as many analyses are conducted on the same datasets. As such, we conduct a scoping review by identifying 80 datasets through the start of 2024 that contain smartphone modalities and depression labels. These datasets originated from 72 manuscripts and approximately 60 research groups. The most collected smartphone modalities included location and/or activity for 68.75%, communication logs for 47.5%, phone use for 41.25%, vocal utterances for 30%, and WiFi and/or Bluetooth connectivity for 28.75% of the datasets. The PHQ-8 and PHQ-9 (Patient Health Questionnaire) were the most popular screening instruments, administered for 53.75% of datasets. Of the 80 datasets, 31.25% recruited from student populations, 22.5% from patient populations, and 7.5% recruited crowdsourced workers. Excluding the nine datasets that did not report demographics, 73% reported a majority of women participants. Given the importance of datasets on analysis outcomes, this scoping review is an invaluable resource to inform the state of science and guide future mobile health research.
Related Concept Videos
Depressive Disorders: MDD and Dysthymia
Depression: Overview
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Diagnostic and Statistical Manual of Mental Disorders (DSM)
Antidepressant Drugs: MAOIs and Other Agents
Long-term Depression

